Genome-wide association study of white-coat effect in hypertensive patients

Background: White-coat effect (WCE) confounds diagnosis and treatment of hypertension. The prevalence of white-coat hypertension is higher in Europe and Asia compared to other continents suggesting that genetic factors could play a role. Methods: To study genetic variation affecting WCE, we conducte...

Full description

Bibliographic Details
Main Authors: Jenni M Rimpelä, Teemu Niiranen, Antti Jula, Ilkka H Pörsti, Antti Tikkakoski, Aki Havulinna, Terho Lehtimäki, Veikko Salomaa, Kimmo K Kontula, Timo P Hiltunen
Format: Article
Language:English
Published: Taylor & Francis Group 2019-07-01
Series:Blood Pressure
Subjects:
Online Access:http://dx.doi.org/10.1080/08037051.2019.1604066
_version_ 1827817832419688448
author Jenni M Rimpelä
Teemu Niiranen
Antti Jula
Ilkka H Pörsti
Antti Tikkakoski
Aki Havulinna
Terho Lehtimäki
Veikko Salomaa
Kimmo K Kontula
Timo P Hiltunen
author_facet Jenni M Rimpelä
Teemu Niiranen
Antti Jula
Ilkka H Pörsti
Antti Tikkakoski
Aki Havulinna
Terho Lehtimäki
Veikko Salomaa
Kimmo K Kontula
Timo P Hiltunen
author_sort Jenni M Rimpelä
collection DOAJ
description Background: White-coat effect (WCE) confounds diagnosis and treatment of hypertension. The prevalence of white-coat hypertension is higher in Europe and Asia compared to other continents suggesting that genetic factors could play a role. Methods: To study genetic variation affecting WCE, we conducted a two-stage genome-wide association study involving 1343 Finnish subjects. For the discovery stage, we used Genetics of Drug Responsiveness in Essential Hypertension (GENRES) cohort (n = 206), providing the mean WCE values from up to four separate office/ambulatory recordings conducted on placebo. Associations with p values <1 × 10−5 were included in the replication step in three independent cohorts: Haemodynamics in Primary and Secondary Hypertension (DYNAMIC) (n = 182), Finn-Home study (n = 773) and Dietary, Lifestyle and Genetic Determinants of Obesity and Metabolic Syndrome (DILGOM) (n = 182). Results: No single nucleotide polymorphisms reached genome-wide significance for association with either systolic or diastolic WCE. However, two loci provided suggestive evidence for association. A known coronary artery disease risk locus rs2292954 in SPG7 associated with systolic WCE (discovery p value = 2.2 × 10−6, replication p value = 0.03 in Finn-Home, meta-analysis p value 2.6 × 10−4), and rs10033652 in RASGEF1B with diastolic WCE (discovery p value = 4.9 × 10−6, replication p value = 0.04 in DILGOM, meta-analysis p value = 5.0 × 10−3). Conclusion: This study provides evidence for two novel candidate genes, SPG7 and RASGEF1B, associating with WCE. Our results need to be validated in even larger studies carried out in other populations.
first_indexed 2024-03-12T00:39:11Z
format Article
id doaj.art-75daf4f67827468caf580984460b4797
institution Directory Open Access Journal
issn 0803-7051
1651-1999
language English
last_indexed 2024-03-12T00:39:11Z
publishDate 2019-07-01
publisher Taylor & Francis Group
record_format Article
series Blood Pressure
spelling doaj.art-75daf4f67827468caf580984460b47972023-09-15T08:45:22ZengTaylor & Francis GroupBlood Pressure0803-70511651-19992019-07-0128423924910.1080/08037051.2019.16040661604066Genome-wide association study of white-coat effect in hypertensive patientsJenni M Rimpelä0Teemu Niiranen1Antti Jula2Ilkka H Pörsti3Antti Tikkakoski4Aki Havulinna5Terho Lehtimäki6Veikko Salomaa7Kimmo K Kontula8Timo P Hiltunen9University of HelsinkiNational Institute for Health and Welfare, Helsinki, FinlandNational Institute for Health and Welfare, Helsinki, FinlandUniversity of Tampere and Tampere University HospitalTampere University HospitalFIMM, University of Helsinki, and Department of Health, National Institute for Health and WelfareUniversity of TampereNational Institute for Health and WelfareUniversity of HelsinkiUniversity of HelsinkiBackground: White-coat effect (WCE) confounds diagnosis and treatment of hypertension. The prevalence of white-coat hypertension is higher in Europe and Asia compared to other continents suggesting that genetic factors could play a role. Methods: To study genetic variation affecting WCE, we conducted a two-stage genome-wide association study involving 1343 Finnish subjects. For the discovery stage, we used Genetics of Drug Responsiveness in Essential Hypertension (GENRES) cohort (n = 206), providing the mean WCE values from up to four separate office/ambulatory recordings conducted on placebo. Associations with p values <1 × 10−5 were included in the replication step in three independent cohorts: Haemodynamics in Primary and Secondary Hypertension (DYNAMIC) (n = 182), Finn-Home study (n = 773) and Dietary, Lifestyle and Genetic Determinants of Obesity and Metabolic Syndrome (DILGOM) (n = 182). Results: No single nucleotide polymorphisms reached genome-wide significance for association with either systolic or diastolic WCE. However, two loci provided suggestive evidence for association. A known coronary artery disease risk locus rs2292954 in SPG7 associated with systolic WCE (discovery p value = 2.2 × 10−6, replication p value = 0.03 in Finn-Home, meta-analysis p value 2.6 × 10−4), and rs10033652 in RASGEF1B with diastolic WCE (discovery p value = 4.9 × 10−6, replication p value = 0.04 in DILGOM, meta-analysis p value = 5.0 × 10−3). Conclusion: This study provides evidence for two novel candidate genes, SPG7 and RASGEF1B, associating with WCE. Our results need to be validated in even larger studies carried out in other populations.http://dx.doi.org/10.1080/08037051.2019.1604066white-coat effecthypertensiongenegenome-widespg7rasgef1b
spellingShingle Jenni M Rimpelä
Teemu Niiranen
Antti Jula
Ilkka H Pörsti
Antti Tikkakoski
Aki Havulinna
Terho Lehtimäki
Veikko Salomaa
Kimmo K Kontula
Timo P Hiltunen
Genome-wide association study of white-coat effect in hypertensive patients
Blood Pressure
white-coat effect
hypertension
gene
genome-wide
spg7
rasgef1b
title Genome-wide association study of white-coat effect in hypertensive patients
title_full Genome-wide association study of white-coat effect in hypertensive patients
title_fullStr Genome-wide association study of white-coat effect in hypertensive patients
title_full_unstemmed Genome-wide association study of white-coat effect in hypertensive patients
title_short Genome-wide association study of white-coat effect in hypertensive patients
title_sort genome wide association study of white coat effect in hypertensive patients
topic white-coat effect
hypertension
gene
genome-wide
spg7
rasgef1b
url http://dx.doi.org/10.1080/08037051.2019.1604066
work_keys_str_mv AT jennimrimpela genomewideassociationstudyofwhitecoateffectinhypertensivepatients
AT teemuniiranen genomewideassociationstudyofwhitecoateffectinhypertensivepatients
AT anttijula genomewideassociationstudyofwhitecoateffectinhypertensivepatients
AT ilkkahporsti genomewideassociationstudyofwhitecoateffectinhypertensivepatients
AT anttitikkakoski genomewideassociationstudyofwhitecoateffectinhypertensivepatients
AT akihavulinna genomewideassociationstudyofwhitecoateffectinhypertensivepatients
AT terholehtimaki genomewideassociationstudyofwhitecoateffectinhypertensivepatients
AT veikkosalomaa genomewideassociationstudyofwhitecoateffectinhypertensivepatients
AT kimmokkontula genomewideassociationstudyofwhitecoateffectinhypertensivepatients
AT timophiltunen genomewideassociationstudyofwhitecoateffectinhypertensivepatients